Remuneration questioned by investors at recent AGMs

Remuneration questioned by investors at recent AGMs

As company accounts come under closer scrutiny amid talk of recession, shareholders continue to take the opportunity at company AGMs to express disapproval with executive pay.

Scapa Group saw significant opposition to its remuneration report and its request to disapply pre-emption rights at its AGM on 7 August 2020.

On 12 February, the AIM 50 company posted a trading update ahead of its financial year end on 31 March 2020, reporting that revenue had decreased from £311.8m in 2019 to around £306m and that the loss of a significant contract with ConvaTec had resulted in a significant decrease in trading profit to approximately £28m. Once the news hit the market, Scapa’s share price dropped from 272 pence per share to 188 pence, its lowest in almost five years.

The impact of the COVID-19 pandemic had a further effect on the share price of the adhesive and wound-care specialist, which dipped down as low as 83.2 pence in July. In May, the company cancelled its dividend and carried out a cashbox placing for 19.99% of the company’s share capital to strengthen the group’s balance sheet and provide flexibility to support future growth initiatives post-COVID-19. The move followed guidance from the Pre-Emption Group released in April, recommending that during the COVID-19 crisis, investors consider supporting non pre-emptive fundraisings of up to 20% of a company’s issued share capital on a temporary basis.

Notwithstanding its financial difficulties, Scapa announced in its

Subscription Form

Already a subscriber? Login
RELX (UK) Limited, trading as LexisNexis, and our LexisNexis Legal & Professional group companies will contact you to confirm your email address. You can manage your communication preferences via our Preference Centre. You can learn more about how we handle your personal data and your rights by reviewing our  Privacy Policy.

Related Articles:
Latest Articles:

Access this article and thousands of others like it free by subscribing to our blog.

Read full article

Already a subscriber? Login

About the author:

Market Tracker is a unique service for corporate lawyers housed within Lexis®PSL Corporate. It features a powerful transaction data analysis tool for accessing, analysing and comparing the specific features of corporate transactions, with a comprehensive and searchable library of deal documentation across 14 different deal types. The Market Tracker product also includes news and analysis of key corporate deals and activity and in-depth analysis of recent trends in corporate transactions.